Cytomed Therapeutics Limited (GDTC)

Feb 6, 2025, 7:20 AM EST - 17 days ago

CytoMed Therapeutics announces Chairman's Letter to the Company's shareholders

Jan 6, 2025, 11:10 AM EST - 6 weeks ago

Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor

Aug 20, 2024, 7:00 AM EDT - 6 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GOSS GOVX IMRN

Jul 17, 2024, 7:00 AM EDT - 7 months ago

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

Mar 20, 2024, 8:30 AM EDT - 1 year ago

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

Mar 18, 2024, 6:00 AM EDT - 1 year ago

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

Mar 4, 2024, 5:00 AM EST - 1 year ago

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Jan 29, 2024, 7:00 AM EST - 1 year ago

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Dec 5, 2023, 7:30 AM EST - 1 year ago

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

Nov 17, 2023, 9:21 AM EST - 1 year ago

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Nov 14, 2023, 7:47 AM EST - 1 year ago

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Oct 24, 2023, 1:00 PM EDT - 1 year ago

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology

Sep 25, 2023, 7:00 AM EDT - 1 year ago

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

Sep 1, 2023, 8:00 PM EDT - 1 year ago

CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch

Aug 29, 2023, 9:00 AM EDT - 1 year ago

CytoMed Expands Research Collaboration into China After Entering Into MOU

Aug 20, 2023, 3:50 AM EDT - 1 year ago

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal

ARQT SMMT

Aug 17, 2023, 7:30 AM EDT - 1 year ago

CytoMed Therapeutics Limited to Present at the August 24th Virtual Investor Summit

Aug 15, 2023, 1:00 PM EDT - 1 year ago

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γD T In Vivo Persistency

Aug 1, 2023, 7:00 AM EDT - 1 year ago

Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Jul 27, 2023, 9:00 AM EDT - 1 year ago

CytoMed Therapeutics Announces U.S. Patent Granted For its Licensed, Novel CAR-Gamma Delta T Cell Technology

Jul 6, 2023, 7:00 AM EDT - 1 year ago

A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US

May 11, 2023, 9:00 AM EDT - 1 year ago

CytoMed Therapeutics to Ring Nasdaq Closing Bell

May 9, 2023, 10:07 AM EDT - 1 year ago

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

Apr 13, 2023, 8:00 PM EDT - 2 years ago

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering

Apr 7, 2023, 5:30 AM EDT - 2 years ago

U.S. IPO Weekly Recap: Small Deals Drive Activity In The IPO Market's Short Week

ARBB ATMU GDHG GMM ISPR KVUE MGIH

Feb 3, 2023, 5:46 PM EST - 2 years ago

IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO